Surufatinib + Serplulimab+Albumin-paclitaxel + Gemcitabine
LAPC2023
Phase 2 small_molecule active
Quick answer
Surufatinib + Serplulimab+Albumin-paclitaxel + Gemcitabine for Locally Advanced Pancreatic Cancer is a Phase 2 program (small_molecule) at Sun Yat-sen University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sun Yat-sen University
- Indication
- Locally Advanced Pancreatic Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active